AtriCure Inc (NASDAQ: ATRC) has reported E.P.S. of $-0.33 for its fourth fiscal quarter (ending December 31) versus $-0.21 for the same period a year ago. This performance was $-0.18 short of the consensus estimate of $-0.15. E.P.S. were $-0.95 for the latest four quarters through December 31 versus $-0.66 for the same period a year ago.
Recent Price Action
On 2/12/25, AtriCure Inc (NASDAQ: ATRC) stock enjoyed a large increase of 2.0%, closing at $42.36. NORMAL trading volume accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 4.2% during the last week.
Current PriceTarget Research Rating
AtriCure has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. AtriCure has a very low Appreciation Score of 14 but a very high Power Rating of 91, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment